Kaempferol attenuates liver fibrosis by inhibiting activin receptor–like kinase 5

Liver fibrosis is a common public health problem. Patients with liver fibrosis are more likely to develop cirrhosis, or hepatocellular carcinoma (HCC) as a more serious consequence. Numerous therapeutic approaches have emerged, but the final clinical outcome remains unsatisfactory. Here, we discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Taifu, Huang, Shan, Huang, Qianrong, Ming, Zhiyong, Wang, Min, Li, Rongrui, Zhao, Yinnong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714241/
https://www.ncbi.nlm.nih.gov/pubmed/31273920
http://dx.doi.org/10.1111/jcmm.14528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714241/
https://www.ncbi.nlm.nih.gov/pubmed/31273920
http://dx.doi.org/10.1111/jcmm.14528

Ejemplares similares